The document discusses different models of relationships between advocacy groups and pharmaceutical companies, from transactional relationships centered around common goals to more independent advocacy. It also examines how advocacy groups and digital resources like WebMD are more trusted sources of health information for consumers than corporate websites or social media. Survey results show that Facebook content from advocacy organizations receives higher ratings than information from pharmaceutical companies.